Clinical Trials
2 trialsNCT04721106 2026-02-10
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Pfizer
Completed
NCT04609319 2025-05-31
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
Pfizer
Completed